Original title: Beijing Stock Exchange’s first share of Guandian defense made its debut
On May 25, Guandian Defense (688287), the first stock transferred to the North Exchange, was officially listed on the Science and Technology Innovation Board. The reference price for the first day of listing was 21.88 yuan per share. It is understood that Guandian Defense took more than half a year from the application to the transfer to the listing. As the first Beijing Stock Exchange stock to successfully transfer the board, Guandian Defense’s transfer experience has given other stocks of the Beijing Stock Exchange who are willing to transfer the board. As a demonstration, the company’s stock’s debut performance on the Science and Technology Innovation Board is also worth looking forward to. In addition, at present, Hanbo High-tech and Taixiang shares are also queuing up to transfer to the board. It is foreseeable that the transfer team will be further expanded in the future.
Officially landed on the Science and Technology Innovation Board
Nearly two months following the Shanghai Stock Exchange agreed to transfer to the board, Guandian Defense officially listed on the Science and Technology Innovation Board on May 25.
It is understood that the share capital of Guandian Defense A shares is regarding 238 million shares, of which regarding 112 million shares have been listed for trading since May 25. The transactions of Guandian Defense following its listing are subject to the relevant regulations of the Shanghai Stock Exchange on companies listed on the Science and Technology Innovation Board. There is no limit on the rise and fall in the first five trading days following listing. .
As the first listed stock on the Beijing Stock Exchange, Guandian Defense has been in the spotlight since the announcement of the transfer. Looking back at the process of Guandian Defense’s transfer to the board, the company’s application for transfer listing was accepted on November 10, 2021, and it entered the inquiry stage from December 3 of that year. It was approved by the meeting on January 27 this year, and March 31 this year. On the same day, the Shanghai Stock Exchange made a decision to approve the listing. On April 26, Guandian Defense officially terminated its listing on the Beijing Stock Exchange. After calculation, it took more than half a year for Guandian Defense to go from filing to listing to listing.
In addition to Guandian Defense, there are currently two stocks on the Beijing Stock Exchange, Hanbo High-tech and Taixiang Co., Ltd., which are queuing up for transfer. However, unlike Guandian Defense, these two stocks are planned to be transferred to the ChiNext for listing.
According to the official website of the Shenzhen Stock Exchange, at present, the transfer process of Hanbo High-tech and Taixiang shares is in the stage of approval by the Listing Committee, waiting for the Shenzhen Stock Exchange to approve the listing. It is understood that the listing application of Hanbo High-tech was accepted on November 9, 2021, entered the inquiry stage on November 12 of the same year, and was approved by the Shanghai Conference on March 10, 2022. Taixiang shares transfer listing application was accepted on November 10, 2021, entered the inquiry stage on November 19 of the same year, and successfully passed the meeting on March 25 this year.
Bai Wenxi, Chief Economist of IPG China, said that with the successful listing of Guandian Defense, the green channel from the Beijing Stock Exchange to the Science and Technology Innovation Board and the Growth Enterprise Market has been successfully opened, which is of great significance for improving the stock liquidity and financing capabilities of companies transferred to the board. At the same time, it is also of great significance to improve the functions of the Beijing Stock Exchange and the New Third Board and enhance the market influence of the Beijing Stock Exchange and the New Third Board.
Regarding the reasons for the transfer, the relevant person in charge of the Guandian Defense Securities Department said in an interview with a reporter from the Beijing Business Daily that the company applied for the transfer for three reasons. First, the company has further developed and expanded its business through the public offering and financing of the selected layer, meeting the requirements for listing on the STAR Market; second, the company pays more attention to the clustering effect of hard technology companies on the STAR Market, and ample capital liquidity can further demonstrate the enterprise value, and improve future financing efficiency; thirdly, the company believes that with the help of the broader platform of the Science and Technology Innovation Board, it can further enhance the company’s reputation, help the company to further recruit talents, and enhance the overall competitiveness of the market.
Talking regarding the expectations following listing on the Science and Technology Innovation Board, the relevant person in charge of Guandian Defense said, “After the successful transfer to the Science and Technology Innovation Board, Guandian Defense has a new platform, and the company believes that it can use the Science and Technology Innovation Board to become more mature and rich in the future. To achieve the improvement of technical strength and the rapid development of business, it will contribute more to the development of my country’s anti-drug business and national security.”
Attributable net profit increased year by year
In the latest transfer listing report disclosed by Guandian Defense, the company updated the latest performance. From 2019 to 2021, Guandian Defense achieved a year-on-year increase in attributable net profit for three consecutive years.
The listing report on the transfer board shows that Guandian Defense is a leading UAV anti-drug service provider in China. The company’s main business is UAV flight services and data processing, as well as the research and development, production and Sales.
Financial data shows that from 2019 to 2021, the operating income of Guandian Defense was regarding 146 million yuan, 180 million yuan, and 223 million yuan; the corresponding net profit attributable to regarding 41.7042 million yuan, 53.4608 million yuan, and 72.2879 million yuan respectively. Yuan.
Guandian Defense said that with the company’s perennial efforts in the field of drone anti-drug and continuous R&D investment, the amount of data accumulated by the company’s anti-drug business has increased year by year, and the data processing algorithm has been continuously optimized. , the company’s service business gross profit margin increased year by year.
However, Guandian Defense also reminded the risk that the market space of the drone anti-drug industry has a certain dependence on the government’s fiscal budget in the anti-drug field. The growth rate of revenue from the anti-drug service business has slowed down and the growth space has been limited, which has an adverse impact on the overall development of the company.
From the perspective of equity relationship, as of the date of the transfer listing application, Gaoming directly holds 41.45% of the shares of Guandian Defense, and is the company’s controlling shareholder and actual controller. Li Zhenbing, CITIC Securities Co., Ltd., Essence Securities Co., Ltd., and Bi Yongsheng are the company’s second to fifth largest shareholders respectively. As of the filing date of this transfer, the number of shareholders of Guandian Defense was 17,600. Among them, public shareholders hold 112.35 million shares, with a shareholding ratio of 47.3%.
In addition, as of the filing date of the transfer listing, the market value of Guandian Defense on the Beijing Stock Exchange was 5.197 billion yuan.
(Editor in charge: Peng Yansong)
Disclaimer:China Net Finance reprints this article for the purpose of conveying more information and does not represent the views and positions of this website. Article content is for reference only and does not constitute investment advice. Investors operate accordingly at their own risk.
